Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Schmidt

Showing results (301-310 of 350) with videos related to

Pageof 35
Sort By:
Pharmacotherapy|October 21, 2025
High-Throughput Screening for Prescribing Cascades Among Real-World Angiotensin-II Receptor Blockers (ARBs) InitiatorsAsinamai M Ndai, Kayla Smith, Shailina Keshwani, et al.
Clinical Pharmacology and Therapeutics|March 13, 2025
Establishment of a Biomarker-Directed Clinical Endpoint Model for Early-Stage Parkinson's Disease PatientsChurni Gupta, Chaejin Kim, Serge Guzy, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 24, 2023
Barriers to global pharmacometrics: educational challenges and opportunities across the globeRobin Michelet, Linda B S Aulin, Jens M Borghardt, et al.
Scientific Reports|January 8, 2025
Worse survival of hepatocellular cancer patients with membranous insulin receptor overexpressionSteffen Markus Heckl, Carolin Schneider, Lukas Kercher, et al.
Plos One|April 5, 2013
Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell linesAnna C Luca, Sabrina Mersch, René Deenen, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Building Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid PhaseSarah Kim, Walter M Yamada, Brandon Duncanson, et al.
Journal of Clinical Pharmacology|February 28, 2018
Regulatory Perspectives in Pharmacometric Models of OsteoporosisKumpal Madrasi, Fang Li, Myong-Jin Kim, et al.
Journal of Clinical Pharmacology|May 16, 2019
Evaluating the Clinical Impact of Formulation Variability: A Metoprolol Extended-Release Case StudySarah Kim, Vishnu D Sharma, Karthik Lingineni, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 3, 2024
Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development toolJuan Francisco Morales, Marian Klose, Yannick Hoffert, et al.
The Journal of Antimicrobial Chemotherapy|November 12, 2013
Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysisMargreke J E Brill, Aletta P I Houwink, Stephan Schmidt, et al.
Pageof 35

Showing results (301-310 of 350) with videos related to

Sort By:
Pageof 35
Pharmacotherapy|October 21, 2025
High-Throughput Screening for Prescribing Cascades Among Real-World Angiotensin-II Receptor Blockers (ARBs) InitiatorsAsinamai M Ndai, Kayla Smith, Shailina Keshwani, et al.
Clinical Pharmacology and Therapeutics|March 13, 2025
Establishment of a Biomarker-Directed Clinical Endpoint Model for Early-Stage Parkinson's Disease PatientsChurni Gupta, Chaejin Kim, Serge Guzy, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 24, 2023
Barriers to global pharmacometrics: educational challenges and opportunities across the globeRobin Michelet, Linda B S Aulin, Jens M Borghardt, et al.
Scientific Reports|January 8, 2025
Worse survival of hepatocellular cancer patients with membranous insulin receptor overexpressionSteffen Markus Heckl, Carolin Schneider, Lukas Kercher, et al.
Plos One|April 5, 2013
Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell linesAnna C Luca, Sabrina Mersch, René Deenen, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Building Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid PhaseSarah Kim, Walter M Yamada, Brandon Duncanson, et al.
Journal of Clinical Pharmacology|February 28, 2018
Regulatory Perspectives in Pharmacometric Models of OsteoporosisKumpal Madrasi, Fang Li, Myong-Jin Kim, et al.
Journal of Clinical Pharmacology|May 16, 2019
Evaluating the Clinical Impact of Formulation Variability: A Metoprolol Extended-Release Case StudySarah Kim, Vishnu D Sharma, Karthik Lingineni, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 3, 2024
Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development toolJuan Francisco Morales, Marian Klose, Yannick Hoffert, et al.
The Journal of Antimicrobial Chemotherapy|November 12, 2013
Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysisMargreke J E Brill, Aletta P I Houwink, Stephan Schmidt, et al.
Pageof 35